Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

July 20, 2014

Study Completion Date

November 28, 2022

Conditions
Prostate Cancer
Interventions
RADIATION

stereotactic body radiation therapy (SBRT)- 45 Gy

Dose of SBRT - 45 Gray (Gy) in five fractions

RADIATION

stereotactic body radiation therapy (SBRT) - 47.5 Gy

Dose of SBRT - 47.5 Gray (Gy) in five fractions

RADIATION

stereotactic body radiation therapy (SBRT) - 50 Gy (Phase 1)

RADIATION

stereotactic body radiation therapy (SBRT) - 50 Gy (Phase 2)

Trial Locations (5)

32806

MD Anderson Cancer Center Orlando Florida, Orlando

55455

University of Minnesota Cancer Center at University of Minnesota, Minneapolis

57201

Prairie Lakes Cancer Center, Watertown

75390

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

80045

University of Colorado Cancer Center at UC Health Sciences Center, Aurora

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT00547339 - Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter